Cutler Group’s Kura Oncology KURA Stock Holding History

Cutler Group’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,700	Closed	-$26K	–	5979
2020 Q4	$26K	Buy	3,700 +2,800	+311%	+$98.4K	﹤0.01%	2480
2020 Q3	$14K	Buy	+900	New	+$19.9K	﹤0.01%	2740

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cutler Group's KURA Position: Q1 2021 in Review

Cutler Group sold out of Kura Oncology (KURA) in Q1 2021, closing a stake of 280 shares — an estimated $8.86K sold.

Cutler Group first reported a position in KURA in Q4 2019 and held it in 4 quarters. The position peaked at $42K in Q3 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

Cutler Group reported no remaining Kura Oncology position as of Q1 2021 after selling out during the quarter.
Cutler Group sold 280 Kura Oncology shares in Q1 2021, an estimated $8.86K.
Cutler Group first reported a position in Kura Oncology in Q4 2019 and held it in 4 quarters.
Cutler Group's Kura Oncology position peaked at $42K in Q3 2020.
171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.